Global biopharma firm HBM raises $75m from GIC, SK Holdings, others

Global biopharma firm HBM raises $75m from GIC, SK Holdings, others

Laboratory equipment. Photo: Pixabay

Global biopharmaceutical firm Harbour BioMed (HBM) announced on Thursday the completion of a Series B+ round of financing at $75 million to accelerate the advancement of its clinical-stage compounds and next-generation biotherapeutics for treating cancer and immunological diseases.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter